Oncology & Cancer

Developments in TACE and SIRT treatment in patients

Data from a number of clinical trials presented today at the International Liver Congress 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma (HCC).

Oncology & Cancer

Increased toxicity for many newly approved anticancer drugs

(HealthDay)—Newly approved anticancer drugs that do not have a specific molecular target on cancer cells are associated with increased toxicity and the accompanying costs of management, according to research published online ...

Oncology & Cancer

Fullerene compounds will help in the fight against lung cancer

A team of scientists from Skoltech Center for Energy Science and Technology, the Institute for Problems of Chemical Physics of Russian Academy of Sciences and National Taiwan University has discovered that fullerene compounds ...

page 4 from 8